This story appears in the June 28, 2015 issue of Forbes. Subscribe
Do you want to invest like George Soros, David Tepper or Larry Robbins?
These are the top trades--ten buys and ten sells--of the world's richest active hedge fund stock pickers. To compile the list, we looked at the U.S. trades of billionaire hedge fund managers in the half-year ending Mar. 31. The top picks are ranked based on the number of billionaires who bought or sold the stock in a material way--at least 10,000 shares. We included picks only if at least six top managers agreed--we excluded some billionaire hedgies, such as Carl Icahn and
Some of the most actively traded stocks pop up on our screen, while some names have garnered less attention. For instance, SunEdison, the world's largest renewable-energy development company, has drawn votes of confidence from 10 hedge fund billionaires as its stock soared 60% year-over-year. On the other hand, 11 top managers lowered their stakes in American Airlines in anticipation of the airline industry's overcapacity. However, hedge fund billionaires can't seem to agree on
Here's one handy graphic that shows the 20 hottest trades (click the image below for an enlarged version):
Note: Billionaires included in the chart above are George Soros, Ray Dalio, Steve Cohen, John Paulson, David Tepper, Paul Tudor Jones II, Daniel Och, Israel Englander, Leon G. Cooperman, Michael Platt, Stanley Druckenmiller, Daniel Loeb, James Dinan, Stephen Mandel Jr., Larry Robbins, Glenn Dubin, Paul Singer, Michael Hintze, David Einhorn.
TOP 10 BUYS
SunEdison
World's largest renewable-energy development firm bought seven portfolios in Asia, Africa and South America.
Iconic carmaker posted stronger-than-expected sales and agreed to repurchase $5 billion worth of stock.
Micron
Longtime hedge-fund darling is still getting hype despite a 22% stock drop in the past year.
T-Mobile
Merger with Dish Network uncertain, but T-Mobile still stands to benefit from broader telecom consolidation.
Plan to spin off
Daniel Loeb's activist fight at Dow has drawn votes of confidence from fellow billionaires.
Dublin-based drug giant beat out Valeant to buy Botox-maker
"China's
Improved profit margin injected confidence as share price rose 13% in the past year.
DirecTV
TOP 10 SELLS
American Airlines
Stock fell 1% over the past year as the airline's first-quarter revenue dropped amid industry's overcapacity.
Alibaba
Despite scoring history's largest-ever IPO, Chinese e-commerce giant has been plagued by counterfeiting accusations.
Hedge-fund investors are pulling back after its planned $54 billion inversion deal with
Biggest for-profit hospital operator by revenue saw its stock soar 52% year-over-year. Time to take gains?
The world's most valuable company now sells a much-hyped watch, but not everyone agrees with Carl Icahn's optimism.
The uncertain fate of the cable company amid the telecom industry's merger mania is drawing concerns.
Despite Carl Icahn's lobbying, Family Dollar chose
Medical device maker restructured its $50 billion merger with
The bank is set to shell out millions in fines to settle accusations of manipulating foreign-exchange rates.
Actavis
Outspent Valeant to buy Allergan. Now the hard part: making the merger work.
Additional reporting by Nathan Vardi.
